Pharmaron Beijing Co., Ltd. (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Pharmaron Beijing Shareholders Equity (Quarterly) : 2.409B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.409B |
| March 31, 2026 | 2.382B |
| December 31, 2025 | 2.156B |
| September 30, 2025 | 2.053B |
| June 30, 2025 | 1.991B |
| March 31, 2025 | 1.936B |
| December 31, 2024 | 1.866B |
| September 30, 2024 | 1.908B |
| June 30, 2024 | 1.791B |
| March 31, 2024 | 1.755B |
| December 31, 2023 | 1.771B |
| September 30, 2023 | 1.603B |
| June 30, 2023 | 1.588B |
| March 31, 2023 | 1.598B |
| December 31, 2022 | 1.489B |
| September 30, 2022 | 1.467B |
| June 30, 2022 | 1.517B |
| Date | Value |
|---|---|
| March 31, 2022 | 1.609B |
| December 31, 2021 | 1.589B |
| September 30, 2021 | 1.510B |
| June 30, 2021 | 1.450B |
| March 31, 2021 | 1.388B |
| December 31, 2020 | 1.356B |
| September 30, 2020 | 1.243B |
| June 30, 2020 | 1.150B |
| March 31, 2020 | 1.108B |
| December 31, 2019 | 1.115B |
| September 30, 2019 | 419.50M |
| June 30, 2019 | 412.61M |
| March 31, 2019 | 420.01M |
| December 31, 2018 | 336.98M |
| September 30, 2018 | 323.67M |
| June 30, 2018 | 319.17M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viva Biotech Holdings | -- |
| ICON plc | 9.378B |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | 3.939M |
| SPO Global, Inc. | -0.3183M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.294B |
| Total Liabilities (Quarterly) | 1.715B |
| Debt to Equity Ratio | 0.4253 |
| Current Ratio | 1.017 |
| Net Debt Paydown Yield | -1.15% |